How does CKD affect bone health and what is a typical management approach?

• A. CKD causes CKD-MBD with bone turnover abnormalities; management includes phosphate binders, vitamin D analogs, calcium balance, and PTH monitoring
• B. Osteoarthritis due to aging; management with NSAIDs
• C. Osteoporosis; treat with bisphosphonates
• D. Hypercalcemia; avoid vitamin D

Answer: (A)

Chronic kidney disease disrupts mineral metabolism, leading to CKD-MBD, a system-wide bone and mineral disorder where phosphate builds up, active vitamin D production falls, and parathyroid hormone levels rise, causing abnormal bone turnover. The kidneys’ reduced ability to excrete phosphate and to activate vitamin D lowers calcium absorption, which stimulates PTH and drives bone remodeling changes that can be high or low in turnover and can promote vascular calcifications.

Management centers on keeping phosphate under control, maintaining calcium in a balanced range, and using active vitamin D to suppress excess PTH while avoiding calcium overload. Phosphate binders are taken with meals to reduce intestinal phosphate absorption, vitamin D analogs help correct deficiency and curb PTH secretion, and calcium balance is monitored to prevent hypercalcemia or vascular calcification. Regular PTH monitoring guides adjustments to therapy to maintain bone turnover in a healthier range.